Crystal structure of a Cas9 in complex with an RNA guide and a stretch of target DNAWIKIMEDIA, H. NISHIMASU ET AL.A team of researchers at the Gladstone Institutes in San Francisco, California, has used a version of CRISPR gene editing known as CRISPR interference (CRISPRi) to reversibly and accurately suppress gene expression in induced pluripotent stem cells (iPSCs) and derivative T cells and heart cells, according to a study published in Cell Stem Cell today (March 10).
CRISPRi, first reported in 2013, relies on a deactivated version of the Cas9 protein, which—together with an inhibitor protein called KRAB—sits on a target gene. Instead of cutting the DNA, the proteins simply block the machinery needed to transcribe the gene from gaining access, thereby suppressing its expression. Comparing this approach to the classic CRISPR/Cas9 system designed to cleave the DNA, the Gladstone team found that CRISPRi is actually more effective, silencing the target gene in more than 95 percent of cells, compared with the 60 percent to 70 percent efficiency of CRISPR/Cas9. Moreover, CRISPRi did not result in any off-target changes in gene expression—a commonly cited problem with CRISPR/Cas9.
“We were amazed by the dramatic difference in performance between the two systems,” study coauthor ...
